Evidence map›Paper›PMID 31693733›Full record

ArticleBioscience reports2019

LncRNA NRON alleviates atrial fibrosis through suppression of M1 macrophages activated by atrial myocytes.

Fei Sun, Zhixiang Guo, Chengxin Zhang, Hong Che, Wenhui Gong, Zhiming Shen, Yinglu Shi, Shenglin Ge

Abstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Non-coding RNA and arrhythmias: expression, function, and molecular mechanism.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Research Progress of Myocardial Fibrosis and Atrial Fibrillation.Frontiers in cardiovascular medicine · 2022
    Review
  16. Review
  17. Long noncoding RNA and atrial fibrillation.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  18. Article
  19. Genetics and Epigenetics of Atrial Fibrillation.International journal of molecular sciences · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fei SunDepartment of Cardiovascular Surgery, First Affiliated Hospital of Anhui Medical University, No.218 Ji-Xi Road, Hefei 230022, China.
Zhixiang GuoDepartment of Cardiovascular Surgery, First Affiliated Hospital of Anhui Medical University, No.218 Ji-Xi Road, Hefei 230022, China.
Chengxin ZhangDepartment of Cardiovascular Surgery, First Affiliated Hospital of Anhui Medical University, No.218 Ji-Xi Road, Hefei 230022, China.
Hong CheDepartment of Cardiovascular Surgery, First Affiliated Hospital of Anhui Medical University, No.218 Ji-Xi Road, Hefei 230022, China.
Wenhui GongDepartment of Cardiovascular Surgery, First Affiliated Hospital of Anhui Medical University, No.218 Ji-Xi Road, Hefei 230022, China.
Zhiming ShenDepartment of Cardiovascular Surgery, First Affiliated Hospital of Anhui Medical University, No.218 Ji-Xi Road, Hefei 230022, China.
Yinglu ShiDepartment of Cardiovascular Surgery, First Affiliated Hospital of Anhui Medical University, No.218 Ji-Xi Road, Hefei 230022, China.
Shenglin GeDepartment of Cardiovascular Surgery, First Affiliated Hospital of Anhui Medical University, No.218 Ji-Xi Road, Hefei 230022, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to explore the role of long non-coding RNA (lncRNA) non-coding repressor of NFAT (NRON) in the atrial fibrosis and to explore whether its underlying mechanism was associated with macrophage polarization. Enzyme-linked immunosorbent assay (ELISA) analysis of pro-inflammatory cytokines revealed that NRON overexpression suppressed, whereas NRON silencing facilitated the angiotensin II (Ang II)-induced inflammatory response in primary cultured atrial myocytes. The chromatin immunoprecipitation (ChIP) results showed that nuclear factor of activated T cell 3 (NFATc3) was recruited to the promoter region of interleukin (IL) 12 (IL-12) in atrial myocytes. Further data showed that NRON overexpression suppressed, whereas NRON silencing further promoted the Ang II-induced NFATc3 nuclear transport and IL-12 expression in atrial myocytes. Moreover, RAW264.7 macrophages were incubated with the conditioned medium from the Ang II-treated atrial myocytes transfected with NRON and IL-12 overexpression vectors. IL-12 overexpression abrogated the NRON overexpression-mediated inhibition of RAW264.7 macrophage polarization to the M1-like phenotype. Additionally, mouse atrial fibroblasts were incubated with the culture medium from RAW264.7 macrophages treated as described above. IL-12 overexpression rescued the NRON overexpression-inhibited protein levels of fibrosis markers Collagen I/III in mouse atrial fibroblasts. Collectively, our data indicate that lncRNA NRON alleviates atrial fibrosis through suppression of M1 macrophages activated by atrial myocytes.

Indexed as

Angiotensin IIAnimalsAtrial FibrillationCells, CulturedCollagen Type ICulture Media, ConditionedFibroblastsFibrosisHeart AtriaMacrophage ActivationMacrophagesMiceMyocytes, CardiacRAW 264.7 CellsRNA, Long NoncodingAngiotensin IICollagen Type ICulture Media, ConditionedNRON long non-coding RNA, mouseRNA, Long Noncodingatrial fibrillation (AF)IL-12M1 macrophagesNRON

Identifiers

PMID31693733
PMCPMC6879354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.